Differential role of IκB kinase 1 and 2 in primary rat hepatocytes

Hepatology

Volumn 33, Issue 1, 2001, Pages 81-90

  Schwabe, Robert F ^a   Bennett, Brydon L ^b   Manning, Anthony M ^b   Brenner, David A ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b CELGENE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE 1; I KAPPA B KINASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE SYNTHASE; NUCLEAR FACTOR I; PROTEIN KINASE; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; SYNAPTOTAGMIN; UNCLASSIFIED DRUG; VIRUS VECTOR;

ARTICLE; CANCER IMMUNOTHERAPY; CELL PROTECTION; CYTOKINE PRODUCTION; EMBRYO; ENZYME MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; IMMUNOSTIMULATION; LIVER CELL; MOUSE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0035153931     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.20799     Document Type: Article

References (53)

1. Phosphorylation meets ubiquitination: The control of NF-[kappa]B activity
2. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
3. Death receptors in liver biology and pathobiology
4. Mechanisms of hepatic toxicity. I. TNF-induced liver injury
5. NF-kappaB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis
6. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death
7. Suppression of TNF-alpha-induced apoptosis by NF-kappaB
8. TNF-cancer therapy-induced apoptosis Potentiation by inhibition of NF-kappaB
9. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B
10. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration
11. NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration
12. High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation
13. Four new members expand the interleukin-I superfamily
14. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist
15. Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients
16. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
17. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms
18. A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB
19. IKK-1 and IKK-2: Cytokine-activated IkappaB kinases essential for NF-kappaB activation
20. Identification and characterization of an IkappaB kinase
21. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex
22. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation
23. IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex
24. IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK
25. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation
26. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation
27. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene
28. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice
29. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis
30. IKK1-deficient mice exhibit abnormal development of skin and skeleton
31. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase
32. Limb and skin abnormalities in mice lacking IKKalpha
33. Characterization of the recombinant IKK1/IKK2 heterodimer. Mechanisms regulating kinase activity
34. NF-kappaB-inducing kinase activates IKKalpha by phosphorylation of Ser- 176
35. Activation of the heterodimeric IkappaB kinase alpha (IKKalpha)-IKKbeta complex is directional: IKKalpha regulates IKKbeta under both basal and stimulated conditions
36. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain
37. Transactivation domain 2 (TA2) of p65 NF-kappa B. Similarity to TA1 and phorbol ester-stimulated activity and phosphorylation in intact cells
38. The mitochondrial permeability transition augments Fas-induced apoptosis in mouse hepatocytes
39. Aberrant rel/nfkb genes and activity in human cancer
40. Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmatic inhibitors of rel-related proteins
41. Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappaB inhibitor IkappaBalpha
42. Ectopic expression of hepatitis C virus protein differentially regulates nuclear transcription factors
43. Activation of nuclear factor kappaB in hepatitis C virus infection: Implications for pathogenesis and hepatocarcinogenesis
44. Irreversible injury in anoxic hepatocytes precipitated by an abrupt increase in plasma membrane permeability
45. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3
46. Labeling neural cells using adenoviral gene transfer of membrane-targeted GFP
47. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei
48. The Mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release
49. NF-kappa B regulation by I kappa B kinase in primary fibroblast-like synoviocytes
50. The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B
51. Inter-action of the COOH-terminal transactivation domain of p65 NFκB with TAT binding protein, transcription factor IIB and coactivators
52. Activation o f nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529
53. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor